ArticleFrontiers in oncology2021
CT-Based Radiomics Signature: A Potential Biomarker for Predicting Postoperative Recurrence Risk in Stage II Colorectal Cancer.
Article in Frontiers in oncology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
25 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- Radiomics and artificial intelligence-based prediction of tumor response in digestive system neoplasm: a systematic review and meta-analysis.Frontiers in medicine · 2026Pooled it
- Predictive Performance of Radiomics-Based Machine Learning for Colorectal Cancer Recurrence Risk: Systematic Review and Meta-Analysis.JMIR medical informatics · 2025Pooled it
- CT-based radiomics signature for optimizing adjuvant chemotherapy decisions in stage II colorectal cancer with proficient mismatch repair.Abdominal radiology (New York) · 2026Article
- Integrating CT-Based Radiomics Analysis With Serum CEA Level to Predict Neoadjuvant Chemoradiotherapy Response in Colorectal Cancer.The Kaohsiung journal of medical sciences · 2026Article
- Development and external validation of an interpretable multimodal deep learning model for 5-year mortality in high-risk stage ii colorectal cancer.International journal of colorectal disease · 2026Article
- Radiomics' Role in Predicting Distant Metastases, Recurrence and Survival Outcome in Rectal Cancer: A Systematic Review.Cancers · 2026Review
- CT-Based Radiomic Signatures Associated with Serum CEA Status in Colon Cancer.Diagnostics (Basel, Switzerland) · 2026Article
- Multimodal radiomics for precision management of colorectal cancer.Discover oncology · 2026Review
- Predicting postoperative recurrence in colorectal cancer using MRI-derived radiomics features and their correlation with the tumor immune microenvironment.Gastroenterology report · 2026Article
- Visualization-driven digital technologies in oncology: current applications, technological advances, and future directions.Frontiers in oncology · 2026Review
- Computed tomography-dominant surveillance strategies for colorectal cancer: Improving early detection of recurrence.World journal of gastrointestinal surgery · 2025Article
- An interpretable CT-based machine learning model for predicting recurrence risk in stage II colorectal cancer.Insights into imaging · 2025Article
- AAbdominal radiology (New York) · 2025Article
- A new paradigm in postoperative colorectal cancer surveillance: integrating advanced imaging and multi-omics.Frontiers in physiology · 2025Review
- Preoperative prediction of early recurrence in patients with BRAF mutant colorectal cancer using a intergrated nomogram.Scientific reports · 2024Article
- A radiomics model for predicting perineural invasion in stage II-III colon cancer based on computer tomography.BMC cancer · 2024Article
- Role of Artificial Intelligence in Surgical Decision-Making: A Comprehensive Review.Galen medical journal · 2024Review
- The Role of Radiomics in Rectal Cancer.Journal of gastrointestinal cancer · 2023Review
- Multi-center evaluation of machine learning-based radiomic model in predicting disease free survival and adjuvant chemotherapy benefit in stage II colorectal cancer patients.Cancer imaging : the official publication of the International Cancer Imaging Society · 2023Article
- Prognostic value of desmoplastic stromal reaction, tumor budding and tumor-stroma ratio in stage II colorectal cancer.Journal of gastrointestinal oncology · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.